Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Barral has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Giuseppe Tosto

    Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, USA

    4 shared publications
  • Nicole Schupf

    The Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA; G.H. Sergievsky Center, Columbia University Medical Center, New York, NY, USA; The Department of Neurology, Columbia University Medical Center, New York, NY, USA; The Department of Epidemiology, Joseph P. Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA

    4 shared publications
  • Richard Mayeux

    Department of Neurology Columbia University Irving Medical Center New York New York USA

    4 shared publications
  • Yizhe Gao

    The G.H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA; The Center for Statistical Genetics, Columbia University Irving Medical Center, New York, NY, USA

    4 shared publications
  • Dolly Reyes‐Dumeyer

    Department of Neurology Columbia University Irving Medical Center New York New York USA

    3 shared publications
  • Joseph H. Lee

    Columbia University Medical Center

    3 shared publications

Latest Publications

  • Open Access

    RBFOX1 association with age at onset of Alzheimer's disease

    by Laura Xicota, Rong Cheng, Stacy L. Andersen, Joseph M. Zmuda, Mary Wojczynski, Mary F. Feitosa, Joseph Bradley, Carlos Cruchaga, Alex G. Contreras, Timothy J. Hohman, et al.

    INTRODUCTION: Genetic contributors to early onset Alzheimer's disease (AD) beyond APP and PSEN1/2 remain unknown. Identifying novel loci may reveal disease mechanisms and therapeutic targets. We investigated genetic variants influencing age at onset in early onset families from the Long‐Life Family Study (LLFS). METHODS: Six families with at least two early onset cases (onset ≤ 65) were identified among 3476 LLFS participants. Genome‐wide linkage analysis of age at onset was followed by single nucleotide polymorphism association. Validation analyses were performed in nine independent cohorts, alongside blood and brain transcriptomic analyses. RESULTS: Three significant linkage regions were identified, including RBFOX1 (logarithm of the odds = 4.41). RBFOX1 variants were associated with age at onset and cognitive phenotypes. A consistent association of RBFOX1 was observed across validation cohorts. Blood transcriptomics revealed RBFOX1 overexpression was associated with an earlier onset. DISCUSSION: RBFOX1 may influence AD age of onset, nominating the gene as a potential therapeutic target for delaying or preventing dementia.

  • Mexican Health and Aging Study Biomarker and Genetic Data Profile

    by Rafael Samper-Ternent, Jesús Daniel Zazueta-Borboa, Alejandra Michaels-Obregon, Dolly Reyes-Dumeyer, Sandra Barral, Giuseppe Tosto, Rebeca Wong

    The Mexican Health and Aging Study (MHAS) is one of the largest ongoing longitudinal studies of aging in Latin America, with six waves over 20 years. MHAS includes sociodemographic, economic, and health data from a nationally representative sample of adults 50 years and older in urban and rural Mexico. MHAS is designed to study the impact of diseases on adults’ health, function, and mortality. As Mexico is experiencing rapid population aging, providing adequate information to study this phenomenon is vital for designing and implementing public policies. The availability of biomarker and genetic data and longitudinal survey data elevates opportunities for research on aging in a low–middle-income country. This manuscript describes the profile of biomarkers and genetic data available in the MHAS study, including sample sizes and sociodemographic characteristics of participants who provided biospecimens for biomarker analyses, emphasizing recent genetic data. The sample size of individuals with anthropometric biomarkers was 2 707 (Wave 1—2001), 2 361 (Wave 2—2003), 2 086 (Wave 3—2012), and 2 051 (2016). Capillary blood samples were collected from 2 063 participants in 2012 (Wave 3) and 1 141 in 2016. Venous blood samples for blood-based biomarkers were collected from 2 003 participants in 2012 (Wave 3) and 752 in 2016. Venous blood samples were also collected for genetic data from 2 010 participants in 2012 (Wave 3) and 750 in 2016. A total of 7 821 participants provided saliva in 2018, and 2 671 provided hair in 2018. From these samples, a total of 7 204 have genome-wide genetic data, 8 600 have apolipoprotein-E genotype data, and 7 156 have genetic ancestry data.


  • Open Access

    Association of APOE with Alzheimer’s disease in Mexico, Caribbean‐Hispanics, Peruvian and Mexican Americans

    by Sandra Barral, Miguel Arce Rentería, Dolly Reyes‐Dumeyer, Silvia Mejia Arango, Alejandra Michaels Obregon, Rafael Samper‐Ternent, Rebeca Wong, Robert Barber, Nicole Phillips, Sid E. O'BRyant, et al.

    Background: The Apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for Late Onset Alzheimer’s disease (LOAD). However, its genetic effect is heterogeneous across different ethnicities. We investigated the association of APOE with LOAD in five different Hispanic studies: Mexicans in the Mexican Health and Aging Study (MHAS), Caribbean Hispanics in the Washington Heights Inwood Aging project (WHICAP), Peruvians in the Genetics of Alzheimer’s disease In Peruvian Populations (GAPP) and Mexican Americans from The Health & Aging Brain among Latino Elders (HABLE) and the Texas Alzheimer’s Research and Care Consortium (TARCC).Method: A total of 7,832 participants were included in the analysis. APOE genotypes were generated by direct genotyping or imputation. SNPs associations with LOAD were assessed using multivariate logistic regression models in PLINK. Analyses were adjusted for age (≥60 years old), sex, and education. Global ancestry proportions, Native Americans, European, African were estimated with ADMIXTURE software using the Human Genome Diversity Project as the reference panel. Genetic ancestry specific secondary analyses were conducted using the same models.Result: The genetic ancestral composition was significantly different across cohorts. Peruvians and Mexicans showed a predominant native ancestry, Caribbean‐Hispanics appeared to have a major contribution of European ancestry, and Mexican Americans exhibited similar proportions of both European and Native ancestries. We observed a significant association with e4 allele dosage in all the cohorts, except for MHAS. The genetic effect of at least one copy of the e4 allele on LOAD risk was very similar in GAPP and HABLE (OR = 3.42, SE = 0.39 and OR = 3.33, SE = 0.33, respectively), while attenuated in TARCC (OR = 2.81, SE = 0.28) and WHICAP (OR = 1.82, SE = 0.16). Among MHAS participants with a predominant European ancestry, APOE association achieved statistical significance with an increased disease risk (OR = 3.42, SE = 0.55) for homozygous carriers. Within the native‐prevalent ancestry subsample, the increased LOAD risk among APOE_ e4 heterozygous carriers were similar in both GAPP and HABLE cohorts (OR = 3.61, SE = 0.44 and OR = 3.64, SE = 0.43, respectively).Conclusion: Our results showed a differential risk for LOAD from the APOE_ e4 allele across populations with admixed genetic ancestry.

  • Open Access

    Examination of Genetic Risk Factors for Alzheimer’s Disease in a Cohort of Familial Longevity: the Long Life Family Study

    by Laura Xicota, Rong Cheng, Sandra Barral, Lawrence S. Honig, Nicole Schupf, Yian Gu, Stephanie Cosentino, Joseph M Zmuda, Thomas T. Perls, Kaare Christensen, et al.

    Background: Genetic risk factors have been explored extensively for late onset Alzheimer’s Disease (LOAD). The largest meta‐analysis GWAS studies to date (Bellenguez et al., 2022) identified 83 single nucleotide polymorphisms (SNPs) associated with LOAD in the general population. The Long Life Family Study (LLFS) is aimed to identify factors associated with familial longevity and healthy aging by examining US and Danish families. Our earlier studies have shown that LLFS families are at lower risk of several age‐related diseases, including LOAD. Here, we will: (1) compare allele frequencies and effect sizes of the identified meta‐GWAS variants against those in LLFS; and (2) assess whether a polygenic risk score (PRS) based on meta‐GWAS variants differs between LOAD vs. cognitively healthy in LLFS.Method: We examined LLFS participants who were Non‐Hispanic Whites, had available cognitive and whole genome sequencing (WGS) (n = 4,220). Allele frequencies were estimated based on founders only. Association analyses were performed via logistic regression using Wald test and adjusting for sex, age, site, education, first principal components, and the genetic relationship matrix. PRS was calculated using a weighted formula, and to account for family structure, means for each status per family were obtained.Result: Independent of LOAD status, 13 SNPs had significantly different allele frequencies between the two studies. Minor allele frequencies of 10 of the SNPs were lower in LLFS when compared with Bellenguez et al. When examining the relations between LOAD and the 77 available SNPs, only five variants appeared to be associated in LLFS. The direction of association differed for two of the SNPs. Lastly, estimated PRS scores did not differ by LOAD status (affected vs unaffected: ‐0.059 vs. ‐0.054, respectively).Conclusion: Here we show that variants associated with LOAD in the general population were not necessarily associated with LOAD in in the LLFS cohort, a cohort ascertained for familial healthy aging. When estimating disease risk using genetic markers, as expected, ascertainment needs to be taken into consideration.

  • Open Access

    Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology

    by Lorraine N. Clark, Yizhe Gao, Gao T. Wang, Nora Hernandez, Allison Ashley-Koch, Joseph Jankovic, Ruth Ottman, Suzanne M. Leal, Sandra M. Barral Rodriguez, Elan D. Louis


  • Open Access

    Association between late maternal age and age-related endophenotypes in the Long Life Family Study

    by Sandra Barral, Stacy L. Andersen, Thomas T. Perls, Harold Bae, Paola Sebastiani, Kaare Christensen, Bharat Thyagarajan, Joseph Lee, Nicole Schupf


  • Open Access

    Association between Late Maternal Age and Age-Related Endophenotypes in the Long Life Family Study

    by Sandra Barral, Stacy L. Andersen, Thomas Perls, Harold Bae, Paola Sebastiani, Kaare Christensen, Bharat Thyagarajan, Joseph H. Lee, Nicole Schupf

    Extended maternal age has been suggested as marker of delayed age-associated disabilities. We use the Long Life Family Study (LLFS) offspring generation to investigate the association between extended maternal age at last childbirth and healthy-aging endophenotypes. We hypothesize that women with extended maternal age at last childbirth will exhibit healthier endophenotype profiles compared to younger mothers. The association between maternal age and age-related endophenotypes previously derived in LLFS was assessed using Generalized Estimating Equations to adjust for relatedness. The quartiles of the maternal age at last childbirth were modeled as the independent variables. Univariate analyses tested the association between maternal age at last childbirth and age at clinical assessment, education, field center, Apolipoprotein E (APOE) genotype, depression, stress, smoking and successful pregnancies. Only the variables significantly associated in the univariate analyses were considered in secondary multivariate analyses. Univariate analyses showed that compared to older mothers (age at last birth≥35), mothers 30 years old or younger at last childbirth are less educated (12 ± 3 years versus 13 ± 3 years) and have a higher frequency of smoking (9% versus 3% for maternal age≥35). Results showed that older mothers (age at last birth≥31-34 or ≥35) demonstrated significantly better cognitive profiles (p=0.017 and p=0.021 respectively) compared with mothers with last childbirth age ≤30. Later maternal age among women from long-life families is associated with a better cognitive profile, supporting the hypothesis that later age at childbirth may be a marker for healthy aging.

  • Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance

    by Yizhe Gao, Daniel Felsky, Dolly Reyes‐Dumeyer, Sanjeev Sariya, Miguel Arce Rentería, Yiyi Ma, Hans‐Ulrich Klein, Stephanie Cosentino, Philip L. De Jager, David A. Bennett, et al.

    Identifying genes underlying memory function will help characterize cognitively resilient and high‐risk declining subpopulations contributing to precision medicine strategies. We estimated episodic memory trajectories in 35,245 ethnically diverse older adults representing eight independent cohorts. We conducted apolipoprotein E (APOE)‐stratified genome‐wide association study (GWAS) analyses and combined individual cohorts’ results via meta‐analysis. Three independent transcriptomics datasets were used to further interpret GWAS signals. We identified DCDC2 gene significantly associated with episodic memory (Pmeta = 3.3 x 10‐8) among non‐carriers of APOE ε4 (N = 24,941). Brain transcriptomics revealed an association between episodic memory maintenance and (1) increased dorsolateral prefrontal cortex DCDC2 expression (P = 3.8 x 10‐4) and (2) lower burden of pathological Alzheimer's disease (AD) hallmarks (paired helical fragment tau P = .003, and amyloid beta load P = .008). Additional transcriptomics results comparing AD and cognitively healthy brain samples showed a downregulation of DCDC2 levels in superior temporal gyrus (P = .007) and inferior frontal gyrus (P = .013). Our work identified DCDC2 gene as a novel predictor of memory maintenance.


  • Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico

    by Miguel Arce Rentería, Jennifer J. Manly, Jet M.J. Vonk, Silvia Mejia Arango, Alejandra Michaels Obregon, Rafael Samper-Ternent, Rebeca Wong, Sandra Barral, Giuseppe Tosto

    Objective: To estimate the prevalence of mild cognitive impairment (MCI) and its subtypes and investigate the impact of midlife cardiovascular risk factors on late-life MCI among the aging Mexican population.Method: Analyses included a sample of non-demented adults over the age of 55 living in both urban and rural areas of Mexico (N = 1807). MCI diagnosis was assigned based on a comprehensive cognitive assessment assessing the domains of memory, executive functioning, language, and visuospatial ability. The normative sample was selected by means of the robust norms approach. Cognitive impairment was defined by a 1.5-SD cut-off per cognitive domain using normative corrections for age, years of education, and sex. Risk factors included age, education, sex, rurality, depression, insurance status, workforce status, hypertension, diabetes, stroke, and heart disease.Results: The prevalence of amnestic MCI was 5.9%. Other MCI subtypes ranged from 4.2% to 7.7%. MCI with and without memory impairment was associated with older age (OR = 1.01 [1.01, 1.05]; OR = 1.03 [1.01, 1.04], respectively) and residing in rural areas (OR = 1.49 [1.08, 2.06]; OR = 1.35 [1.03, 1.77], respectively). Depression (OR = 1.07 [1.02, 1.12]), diabetes (OR = 1.37 [1.03, 1.82]), and years of education (OR = 0.94 [0.91, 0.97]) were associated with MCI without memory impairment. Midlife CVD increased the odds of MCI in late-life (OR = 1.76 [1.19, 2.59], which was driven by both midlife hypertension and diabetes (OR = 1.70 [1.18, 2.44]; OR = 1.88 [1.19, 2.97], respectively).Conclusions: Older age, depression, low education, rurality, and midlife hypertension and diabetes were associated with higher risk of late-life MCI among older adults in Mexico. Our findings suggest that the causes of cognitive impairment are multifactorial and vary by MCI subtype.


  • APOE‐stratified, genome‐wide, gene‐based analysis of episodic memory trajectories in a multi‐ethnic sample of 24,769 elderly

    by Yizhe Gao, Badri N. Vardarajan, Dolly Reyes‐Dumeyer, Sanjeev Sariya, Richard Mayeux, Giuseppe Tosto, Sandra Barral

    Background: Understanding genetic modulation of episodic memory will yield insight into the biological mechanisms underlying normal cognitive aging and dementia. Genetic studies based on longitudinal measures of episodic memory are scarce, predominantly focused on candidate genes, and have interrogated common genetic variation. We aimed to identify common and rare genetic variation that may be responsible for uncharacterized genetic risk underlying individual differences in longitudinal performance on memory.Method: A sample of 24,769 elderly individuals was ascertained from eight independent cohorts (ADGC_NACC, NIA‐LOAD, ROSMAP, WHICAP, LLFS, CHAP, ADNI and UK Biobank). Data on study participants included socio‐demographic variables, longitudinal scores on episodic memory (2 to 15 follow‐up visits), clinical diagnosis of cognitive impairment and genome‐wide imputed genotyped data using the haplotype reference consortium for accurate imputation of low‐frequency genetic variants. The Latent Class Mixed Model was used to derive episodic memory trajectories within each of the study cohorts. The slope of residualized episodic memory scores was used as outcome in an APOE stratified (non‐APOE stratified, APOE_ε4 and APOE_nonε4 sub‐samples) genome‐wide gene‐based analyses. Common (minimum allele frequency, MAF, between 5%‐10%), rare (1% < MAF ≤ 5%) and ultra‐rare variants (≤1% MAF) were analyzed. Association results from each study cohort within each sub‐sample were meta‐analyzed.Result: Consistent with previous studies, the majority of the study participants maintain their memory performance over time (ranging from 51% to 98%). The strongest association signal for the episodic memory trajectories (p = 4.8 × 10−8) was achieved at chromosomal region 6p22 among in the APOE_nonε4 sub‐sample. Meta‐analysis results in the non‐APOE stratified and APOE_ε4 sub‐samples also yielded several chromosomal regions associated with memory performance over time, although significance level was diminished (p∼ 10−6).Conclusion: To our knowledge, this is the largest gene‐based GWAS meta‐analysis of high quality imputed common, rare and ultra‐rare variants influence on episodic memory performance over time. Identifying genes associated with progression of episodic memory performance over time in older adulthood provides the possibility of identifying at‐risk population subgroups that can benefit from possible interventions to enhance cognitive function.